close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by AKAMPION

< Previous 1 2 3 Next >
News headline image
AMYRA Successfully Demonstrates a New Therapeutic Paradigm for Gluten-Related Disorders in a First-in-Human Study
From AKAMPION
Via GlobeNewswire
News headline image
Preliminary Data of BellaSeno’s Clinical Trial on Scaffold-Guided Breast Regeneration Presented at the 93rd Annual Plastic Surgery Meeting in San Diego, CA
From AKAMPION
Via GlobeNewswire
News headline image
Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs
From AKAMPION
Via GlobeNewswire
News headline image
ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base
From AKAMPION
Via GlobeNewswire
News headline image
ImmunOs Therapeutics Expands Phase I Clinical Trial of IOS-1002 in Combination with KEYTRUDA® (pembrolizumab) for the Treatment of Solid Tumors
From AKAMPION
Via GlobeNewswire
News headline image
BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patients
From AKAMPION
Via GlobeNewswire
News headline image
Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer
From AKAMPION
Via GlobeNewswire
News headline image
BellaSeno Receives Financial Support Through Queensland’s Industry Partnership Program
From AKAMPION
Via GlobeNewswire
News headline image
selectION Announces Initiation of Phase 1b Clinical Trial Evaluating si-544 in Patients with Psoriasis Vulgaris or Psoriatic Arthritis
From AKAMPION
Via GlobeNewswire
News headline image
Captain T Cell Secures Seed Financing Round Totaling € 8.5 Million
From AKAMPION
Via GlobeNewswire
News headline image
Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update
From AKAMPION
Via GlobeNewswire
News headline image
selectION Announces Positive Results from Phase 1b Clinical Trial Evaluating si-544 in Patients with Atopic Dermatitis
From AKAMPION
Via GlobeNewswire
News headline image
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track Record
From AKAMPION
Via GlobeNewswire
News headline image
BellaSeno Appoints Dr. Thomas Lingner as Chief Technology Officer and Inga Freyert as VP Quality and Regulatory Affairs
From AKAMPION
Via GlobeNewswire
News headline image
MetrioPharm Establishes Scientific Advisory Board of Seasoned Immunology and Pediatric Experts
From AKAMPION
Via GlobeNewswire
News headline image
BellaSeno’s 3D-printed Resorbable Scaffold Successfully Used in Critical-Size Large Segmental Radius Bone Defect at Hannover Medical School
From AKAMPION
Via GlobeNewswire
News headline image
Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6
From AKAMPION
Via GlobeNewswire
News headline image
Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001
From AKAMPION
Via GlobeNewswire
News headline image
MetrioPharm Publishes First Trial Data Showing Effects of Host-Directed Therapy in COVID-19
From AKAMPION
Via GlobeNewswire
News headline image
New investigator-initiated clinical trials of BellaSeno´s resorbable tissue regeneration scaffolds to be conducted in Europe
From AKAMPION
Via GlobeNewswire
News headline image
selectION, Inc. to Present Update on Clinical Progress at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024
From AKAMPION
Via GlobeNewswire
News headline image
1ST Biotherapeutics, Inc. Announces First Patient Dosed in Phase I/II Study of HPK1 Inhibitor FB849 in Patients with Advanced Solid Tumors
From AKAMPION
Via GlobeNewswire
News headline image
ImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023
From AKAMPION
Via GlobeNewswire
News headline image
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board
From AKAMPION
Via GlobeNewswire
News headline image
EBViously Presents Novel In-Vitro Data Demonstrating Potent Infection Prevention of its Vaccine Candidate EBV-001
From AKAMPION
Via GlobeNewswire
News headline image
Ebenbuild to Receive Public Funding Under UBIC Consortium for Digital Lung Twin Project
From AKAMPION
Via GlobeNewswire
News headline image
Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its Next-Generation Anti-Infective OMN6
From AKAMPION
Via GlobeNewswire
News headline image
Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
From AKAMPION
Via GlobeNewswire
News headline image
BellaSeno Presents Novel Production Workflow for Customized, 3D-Printed Bone Scaffolds
From AKAMPION
Via GlobeNewswire
News headline image
ImmunOs Therapeutics Presents Overview of Phase 1a/b Trial of Lead Compound IOS-1002
From AKAMPION
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today